Gene · 6392
Papers2,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Disordered-to-ordered transitions in assembly factors allow the complex II catalytic subunit to switch binding partners. | Nat Commun | 2024 | 38212624 | PubTator, text mining | PubMed |
| Association of abnormal NDUFB2 and UQCRH expression with venous thromboembolism in patients with liver cirrhosis. | Medicine (Baltimore) | 2024 | 38181234 | PubTator, text mining | PubMed |
| Astrocytes Drive Divergent Metabolic Gene Expression in Humans and Chimpanzees. | Genome Biol Evol | 2024 | 38159045 | PubTator, text mining | PubMed |
| Complex II ambiguities-FADH2 in the electron transfer system. | J Biol Chem | 2024 | 38118236 | PubTator, text mining | PubMed |
| Single-cell RNA-seq and single-cell bisulfite-sequencing reveal insights into yak preimplantation embryogenesis. | J Biol Chem | 2024 | 38097189 | PubTator, text mining | PubMed |
| [Genealogical tree study in patients with familial paraganglioma syndrome due to SDHD mutation]. | Med Clin (Barc) | 2024 | 38042737 | PubTator, text mining | PubMed |
| Hereditary succinate dehydrogenase-deficient renal cell carcinoma. | Semin Diagn Pathol | 2024 | 37981479 | PubTator, text mining | PubMed |
| Th17 cells target the metabolic miR-142-5p-succinate dehydrogenase subunit C/D (SDHC/SDHD) axis, promoting invasiveness and progression of cervical cancers. | Mol Oncol | 2024 | 37899663 | PubTator, text mining | PubMed |
| Head and Neck Malignant Paragangliomas: Experience from a Single Institution. | Ear Nose Throat J | 2024 | 34654328 | PubTator, text mining | PubMed |
| Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemia. | Front Oncol | 2023 | 38260858 | PubTator, text mining | PubMed |
| A Case of Von Hippel-Lindau Disease With Recurrence of Paraganglioma and No Other Associated Symptoms: The Importance of Genetic Testing and Establishing Follow-Up Policies. | Cureus | 2023 | 38222164 | PubTator, text mining | PubMed |
| Endocrine Hypertension: The Urgent Need for Greater Global Awareness. | touchREV Endocrinol | 2023 | 38187076 | PubTator, text mining | PubMed |
| Development and internal validation of a novel predictive model for SDHB mutations in pheochromocytomas and retroperitoneal paragangliomas. | Front Endocrinol (Lausanne) | 2023 | 38179299 | PubTator, text mining | PubMed |
| Local recurrence and metastatic disease in pheochromocytomas and sympathetic paragangliomas. | Front Endocrinol (Lausanne) | 2023 | 38155946 | PubTator, text mining | PubMed |
| An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma. | Front Endocrinol (Lausanne) | 2023 | 38152133 | PubTator, text mining | PubMed |
| Long-acting dolutegravir formulations prevent neurodevelopmental impairments in a mouse model. | Front Pharmacol | 2023 | 38149054 | PubTator, text mining | PubMed |
| High incidence of occult familial SDHD cases amongst Czech patients with head and neck paragangliomas. | Front Endocrinol (Lausanne) | 2023 | 38144572 | PubTator, text mining | PubMed |
| Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer. | Curr Issues Mol Biol | 2023 | 38132457 | PubTator, text mining | PubMed |
| A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide. | Clin Epigenetics | 2023 | 38124114 | PubTator, text mining | PubMed |
| Multifocal gastrointestinal stromal tumor with osseous metaplasia: a case report. | J Med Case Rep | 2023 | 38098096 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6392/papers?page=8